论文部分内容阅读
目的:分析医院2013年—2015年间癌症患者三阶梯镇痛药物的临床使用情况,为临床合理使用镇痛药物提供参考。方法:提取医院HIS系统中2013年—2015年癌症患者三阶梯镇痛药物的临床使用相关数据,分析7种癌症患者药品使用金额、用药频率(DDDs)和日均费用(DDC)。结果:7种癌症患者的镇痛药物以第三阶梯用药为主,其使用金额和DDDs为最高,DDC用前三位分别是地佐辛注射液、羟考酮缓释片和芬太尼透皮贴。结论:医院癌症患者三阶梯镇痛药物的临床使用属基本合理,但仍需要进一步加强监管。
OBJECTIVE: To analyze the clinical use of three-step analgesic drugs in cancer patients from 2013 to 2015 in hospitals and provide a reference for the clinical use of analgesics. Methods: The data of clinical use of three-step analgesic drugs for cancer patients from 2013 to 2015 in hospital HIS system were extracted, and the drug usage, DDDs and DDC of seven kinds of cancer patients were analyzed. Results: The analgesic drugs of 7 kinds of cancer patients were dominated by the third step medication with the highest amount of use and DDDs. The top three DDC patients were dezocine injection, oxycodone sustained-release tablets and fentanyl permeation Paste. Conclusion: The clinical use of three-step analgesic drugs in hospital cancer patients is basically reasonable, but it still needs to be further strengthened.